Distribution of free and conjugated cannabinoids in human bile samples

Forensic Science International

Volumn 223, Issue 1-3, 2012, Pages 114-118

  Fabritius, Marie ^a   Staub, Christian ^a   Mangin, Patrice ^a   Giroud, Christian ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

Bile; Enterohepatic recirculation; Glucuronides; LC MS MS; Tetrahydrocannabinol; THC

Indexed keywords

11 HYDROXYDRONABINOL; CANNABIDIOL; CANNABINOL; CANNABIS; DRONABINOL; GLUCURONIDE; TETRAHYDROCANNABINOLIC ACID;

ACCURACY; ARTICLE; AUTOPSY; BILE FLOW; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HYDROPHOBICITY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SCREENING TEST; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; URINE LEVEL;

EID: 84870298987     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2012.08.013     Document Type: Article

References (23)

1. Yamamoto I., Watanabe K., Narimatsu S., Yoshimura H. Recent advances in the metabolism of cannabinoids. Int. J. Biochem. Cell Biol. 1995, 27:741-746.
2. Roberts M.S., Magnusson B.M., Burczynski F.J., Weiss M. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin. Pharmacokinet. 2002, 41:751-790.
3. Lin D.L., Lin R.L. Distribution of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in traffic fatality cases. J. Anal. Toxicol. 2005, 29:58-61.
4. Gronewold A., Skopp G. A preliminary investigation on the distribution of cannabinoids in man. Forensic Sci. Int. 2011, 210:e7-e11.
5. Hasegawa Y., Kishimoto S., Shibatani N., Nomura H., Ishii Y., Onishi M., Inotsume N., Takeuchi Y., Fukushima S. The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver. J. Pharm. Pharmacol. 2010, 62:310-314.
6. St-Pierre M.V., Pang K.S. Determination of diazepam and its metabolites by high-performance liquid chromatography and thin-layer chromatography. J. Chromatogr. 1987, 421:291-307.
7. Toennes S.W., Ramaekers J.G., Theunissen E.L., Moeller M.R., Kauert G.F. Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J. Anal. Toxicol. 2008, 32:470-477.
8. M. Fabritius, C. Staub, P. Mangin, C. Giroud, Analysis of cannabinoids in oral fluid by liquid chromatography-tandem mass spectrometry. Forensic Toxicol., accepted for publication.
9. Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L., Rozet E. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal - part II. J. Pharm. Biomed. Anal. 2007, 45:70-81.
10. Hubert P., Nguyen-Huu J.J., Boulanger B., Chapuzet E., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Laurentie M., Mercier N., Muzard G., Valat L., Rozet E. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal - part III. J. Pharm. Biomed. Anal. 2007, 45:82-96.
11. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
12. Wohlfarth A., Roth N., Auwarter V. LC-MS/MS analysis of delta9-tetrahydrocannabinolic acid A in serum after protein precipitation using an in-house synthesized deuterated internal standard. J. Mass Spectrom. 2012, 47:778-785.
13. Kipp H., Arias I.M. Trafficking of canalicular ABC transporters in hepatocytes. Annu. Rev. Physiol. 2002, 64:595-608.
14. Holland M.L., Allen J.D., Arnold J.C. Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). Eur. J. Pharmacol. 2008, 591:128-131.
15. Glaz-Sandberg A., Dietz L., Nguyen H., Oberwittler H., Aderjan R., Mikus G. Pharmacokinetics of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (CTHC) after intravenous administration of CTHC in healthy human subjects. Clin. Pharmacol. Ther. 2007, 82:63-69.
16. Johansson E., Agurell S., Hollister L.E., Halldin M.M. Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users. J. Pharm. Pharmacol. 1988, 40:374-375.
17. Huestis M.A. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol. Handb. Exp. Pharmacol. 2005, 657-690.
18. Mazur A., Lichti C.F., Prather P.L., Zielinska A.K., Bratton S.M., Gallus-Zawada A., Finel M., Miller G.P., Radominska-Pandya A., Moran J.H. Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids. Drug Metab. Dispos. 2009, 37:1496-1504.
19. Huestis M.A. Human cannabinoid pharmacokinetics. Chem. Biodivers. 2007, 4:1770-1804.
20. Leighty E.G., Fentiman A.F., Foltz R.L. Long-retained metabolites of delta9- and delta8-tetrahydrocannabinols identified as novel fatty acid conjugates. Res. Commun. Chem. Pathol. Pharmacol. 1976, 14:13-28.
21. Moore C., Rana S., Coulter C. Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2007, 852:459-464.
22. Jung J., Kempf J., Mahler H., Weinmann W. Detection of delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS. J. Mass Spectrom. 2007, 42:354-360.
23. Garrett E.R., Hunt C.A. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs. J. Pharm. Sci. 1977, 66:395-407.